an anti-TNF compound (trade name Arava) that is given orally; can slow the progression of rheumatoid arthritis by slowing the proliferation of white blood cells which reduces inflammation in the synovium
a disease-modifying anti-rheumatic drug that works by inhibiting the formation of the immune cells, which lead to inflammation.
Arava was the first orally-administered drug for treating rheumatoid arthritis. It is a Disease-Modifying AntiRheumatic Drug, a class of drugs that relieve pain and slow the disease's progression but also carry health risks. Arava has been linked to increased chance of liver damage vs. other DMARD drugs.